Alice Roth - Marpai Pres Labs
| MRAI Stock | USD 0.59 0.00 0.000005% |
Insider
Alice Roth is Pres Labs of Marpai Inc
| Age | 62 |
| Address | 615 Channelside Drive, Tampa, FL, United States, 33602 |
| Phone | 855 389 7330 |
| Web | https://www.marpaihealth.com |
Marpai Management Efficiency
The company has return on total asset (ROA) of (0.412) % which means that it has lost $0.412 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.5959) %, meaning that it created substantial loss on money invested by shareholders. Marpai's management efficiency ratios could be used to measure how well Marpai manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Marpai's Return On Capital Employed is increasing as compared to previous years. The Marpai's current Return On Equity is estimated to increase to 0.96, while Return On Tangible Assets are projected to decrease to (1.68). As of now, Marpai's Fixed Asset Turnover is increasing as compared to previous years. The Marpai's current Asset Turnover is estimated to increase to 2.07, while Net Tangible Assets are forecasted to increase to (11.6 M).Similar Executives
| Found 13 records | INSIDER Age | ||
| Daniel Sitar | BioMark Diagnostics | N/A | |
| Sara Zelkovic | Celyad Oncology SA | N/A | |
| David Georges | Celyad Oncology SA | N/A | |
| Martin Beland | DIAGNOS | N/A | |
| Frdric Lehmann | Celyad Oncology SA | 59 | |
| MarcAndr Massue | DIAGNOS | N/A | |
| Jeff Haince | BioMark Diagnostics | N/A | |
| An Phan | Celyad Oncology SA | N/A | |
| Hannes Iserentant | Celyad Oncology SA | N/A | |
| MD MBChB | Celyad Oncology SA | 57 | |
| BME MBA | Celyad Oncology SA | 66 | |
| Guoyu MBA | BioMark Diagnostics | N/A | |
| Philippe Nobels | Celyad Oncology SA | 57 | |
Management Performance
| Return On Equity | -13.6 | ||||
| Return On Asset | -0.41 |
Marpai Inc Leadership Team
Elected by the shareholders, the Marpai's board of directors comprises two types of representatives: Marpai inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marpai. The board's role is to monitor Marpai's management team and ensure that shareholders' interests are well served. Marpai's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marpai's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Powers, President COO | ||
| Steve Johnson, CFO Secretary | ||
| Gonen Antebi, Chief Officer | ||
| Ronnie Brown, Chief Officer | ||
| Lutz Finger, Pres Devel | ||
| Edmundo Gonzalez, CEO, CoFounder | ||
| Eli David, Chairman CoFounder | ||
| Dallas Scrip, President COO | ||
| Yoram Bibring, Chief Officer | ||
| Simon Li, Vice President | ||
| Damien Lamendola, CEO Director | ||
| Richard Brewer, Chief Officer | ||
| Arthur IV, Chief Officer | ||
| Pamela Burns, Vice Sales | ||
| Alice Roth, Pres Labs | ||
| Yaron Eitan, CoFounder Chairman |
Marpai Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Marpai a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.6 | ||||
| Return On Asset | -0.41 | ||||
| Profit Margin | (0.58) % | ||||
| Operating Margin | (0.69) % | ||||
| Current Valuation | 17.31 M | ||||
| Shares Outstanding | 23.88 M | ||||
| Shares Owned By Insiders | 48.75 % | ||||
| Shares Owned By Institutions | 5.55 % | ||||
| Number Of Shares Shorted | 11.51 K | ||||
| Price To Book | 1.49 X |
Currently Active Assets on Macroaxis
When determining whether Marpai Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Marpai's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Marpai Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Marpai Inc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marpai Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Marpai. If investors know Marpai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Marpai listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Revenue Per Share | Quarterly Revenue Growth (0.42) | Return On Assets | Return On Equity |
The market value of Marpai Inc is measured differently than its book value, which is the value of Marpai that is recorded on the company's balance sheet. Investors also form their own opinion of Marpai's value that differs from its market value or its book value, called intrinsic value, which is Marpai's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Marpai's market value can be influenced by many factors that don't directly affect Marpai's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Marpai's value and its price as these two are different measures arrived at by different means. Investors typically determine if Marpai is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marpai's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.